Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03949777Not ApplicableCompleted

Validation of Aer-O-Scope Colonoscope System Cecal Intubation

Role: lead

NCT02926209Not ApplicableTerminated

Post Market Evaluation of Aer-O-Scope Visualization

Role: lead

NCT00867724Not ApplicableCompleted

Clinical Study-evaluate Performance&Safety "Aer-O-Scope" in Colon of Low Risk Patients

Role: lead

NCT02102412Phase 1Terminated

First in Man Aer-O-Scope

Role: lead

All 4 trials loaded